Home › Endometrial Cancer › Oregon › Eugene
Endometrial Cancer clinical trials in Eugene, OR
8 studies for Endometrial Cancer are looking for participants at sites in and around Eugene (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
RecruitingPhase 3
- Oncology Associates of Oregon, P.C. ( Site 8005), Eugene
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
RecruitingPhase 3
- Willamette Valley Cancer Institute and Research Center - Eugene, Eugene
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RecruitingPhase 3
- Research Site, Eugene
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- USOR Oncology Associates of Oregon, P.C., Eugene
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RecruitingPhase 3
- Research Site, Eugene
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RecruitingPhase 2
- 517, Eugene
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
RecruitingPhase 2
- Oncology Associates of Oregon, P.C., Eugene
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
RecruitingPhase 2/3
- Oncology Associates of Oregon, Eugene
Endometrial Cancer trials in other cities
- Houston, TX69 studies
- New York City, NY53 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN37 studies
- Los Angeles, CA35 studies
- St. Louis, MO29 studies
- Philadelphia, PA29 studies
- San Antonio, TX27 studies
- Columbus, OH26 studies
- Chicago, IL26 studies
- Queens, NY26 studies
Other studies in Eugene
- Non-Small Cell Lung Cancer13 studies
- Ovarian Cancer9 studies
- Chronic Lymphocytic Leukemia7 studies
- Breast Cancer7 studies
- Metastatic Cancer6 studies
- Cancer (all types)6 studies
- Multiple Myeloma6 studies
- Lung Cancer5 studies
- Macular Degeneration5 studies
- Drug Use and Addiction5 studies
- Obesity4 studies
- Wet Macular Degeneration3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.